PL371180A1 - Pyrimidotriazines as phosphatase inhibitors - Google Patents

Pyrimidotriazines as phosphatase inhibitors

Info

Publication number
PL371180A1
PL371180A1 PL02371180A PL37118002A PL371180A1 PL 371180 A1 PL371180 A1 PL 371180A1 PL 02371180 A PL02371180 A PL 02371180A PL 37118002 A PL37118002 A PL 37118002A PL 371180 A1 PL371180 A1 PL 371180A1
Authority
PL
Poland
Prior art keywords
pyrimidotriazines
phosphatase inhibitors
pyrimido
triazine
useful
Prior art date
Application number
PL02371180A
Other languages
English (en)
Polish (pl)
Inventor
Kevin Richard Guertin
Lina Quattrocchio Setti
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of PL371180A1 publication Critical patent/PL371180A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL02371180A 2001-12-27 2002-12-27 Pyrimidotriazines as phosphatase inhibitors PL371180A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34393701P 2001-12-27 2001-12-27
US39911002P 2002-07-26 2002-07-26

Publications (1)

Publication Number Publication Date
PL371180A1 true PL371180A1 (en) 2005-06-13

Family

ID=26993696

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02371180A PL371180A1 (en) 2001-12-27 2002-12-27 Pyrimidotriazines as phosphatase inhibitors

Country Status (19)

Country Link
US (1) US6642381B2 (OSRAM)
EP (1) EP1467996B1 (OSRAM)
JP (1) JP4188839B2 (OSRAM)
KR (1) KR100601769B1 (OSRAM)
CN (1) CN100402530C (OSRAM)
AT (1) ATE311388T1 (OSRAM)
AU (1) AU2002367190B2 (OSRAM)
BR (1) BR0215395A (OSRAM)
CA (1) CA2471265C (OSRAM)
DE (1) DE60207759T2 (OSRAM)
ES (1) ES2252554T3 (OSRAM)
JO (1) JO2242B1 (OSRAM)
MX (1) MXPA04006266A (OSRAM)
PA (1) PA8562901A1 (OSRAM)
PE (1) PE20030896A1 (OSRAM)
PL (1) PL371180A1 (OSRAM)
TW (1) TW200306313A (OSRAM)
UY (1) UY27606A1 (OSRAM)
WO (1) WO2003055883A1 (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002342859B2 (en) * 2001-10-30 2007-07-26 Merck Serono Sa Oxindole hydrazide modulators of protein tyrosine phosphatases (PTPS)
DE60327097D1 (de) 2002-11-18 2009-05-20 Hoffmann La Roche Diazinopyrimidine und ihre verwendung als proteinkinaseinhibitoren
JP2006518738A (ja) * 2003-02-12 2006-08-17 トランス　テック　ファーマ，インコーポレイテッド 治療薬としての置換アゾール誘導体
WO2004071448A2 (en) * 2003-02-12 2004-08-26 Transtech Pharma Inc. Substituted azole derivatives as inhibitors of protein tyrosine phosphatases
CA2551909C (en) * 2004-02-12 2011-10-11 Transtech Pharma, Inc. Substituted azole derivatives, compositions, and methods of use
US20080125403A1 (en) 2004-04-02 2008-05-29 Merck & Co., Inc. Method of Treating Men with Metabolic and Anthropometric Disorders
US7723369B2 (en) * 2006-01-30 2010-05-25 Transtech Pharma, Inc. Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2393885T7 (es) 2007-06-04 2014-01-30 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
WO2009149279A2 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2010083645A1 (en) * 2009-01-21 2010-07-29 Shanghai Targetdrug Co., Ltd PYRIMIDO[5,4-e][1,2,4]TRIAZINES AND USES THEREOF
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9486433B2 (en) 2012-10-12 2016-11-08 Mochida Pharmaceuticals Co. Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
US10441560B2 (en) 2013-03-15 2019-10-15 Mochida Pharmaceutical Co., Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
SG11201507288UA (en) 2013-03-15 2015-10-29 Mochida Pharm Co Ltd Compositions and methods for treating non-alcoholic steatohepatitis
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
EP3004138B1 (en) 2013-06-05 2024-03-13 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194410B1 (en) * 1998-03-11 2001-02-27 Hoffman-La Roche Inc. Pyrazolopyrimidine and pyrazolines and process for preparation thereof
PA8474101A1 (es) 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
GB0022079D0 (en) 2000-09-08 2000-10-25 Inst Of Molecul & Cell Biology Novel protein tyrosine phosphatase inhibitor

Also Published As

Publication number Publication date
WO2003055883A1 (en) 2003-07-10
CN1610683A (zh) 2005-04-27
PE20030896A1 (es) 2003-11-05
US6642381B2 (en) 2003-11-04
AU2002367190B2 (en) 2006-10-05
ATE311388T1 (de) 2005-12-15
ES2252554T3 (es) 2006-05-16
JP2005517677A (ja) 2005-06-16
CA2471265A1 (en) 2003-07-10
EP1467996B1 (en) 2005-11-30
CA2471265C (en) 2010-02-09
EP1467996A1 (en) 2004-10-20
KR100601769B1 (ko) 2006-07-19
DE60207759T2 (de) 2006-08-03
JO2242B1 (en) 2004-10-07
CN100402530C (zh) 2008-07-16
KR20040068981A (ko) 2004-08-02
MXPA04006266A (es) 2004-09-27
US20030153756A1 (en) 2003-08-14
TW200306313A (en) 2003-11-16
DE60207759D1 (de) 2006-01-05
BR0215395A (pt) 2004-12-07
AU2002367190A1 (en) 2003-07-15
PA8562901A1 (es) 2003-07-28
JP4188839B2 (ja) 2008-12-03
UY27606A1 (es) 2003-06-30

Similar Documents

Publication Publication Date Title
PL371180A1 (en) Pyrimidotriazines as phosphatase inhibitors
IL160915A0 (en) Indolizines inhibiting kinase proteins
MY134136A (en) Novel compounds comprising jak3 kinase inhibitors
MXPA05012025A (es) Imidazo y tiazolopiridinas como inhibidores de cinasa jak3.
ATE227567T1 (de) Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption
TW200510407A (en) Novel pyrrolodihydroisoquinolines as PDE 10 inhibitors
NO20073801L (no) Atineoplastiske kombinasjoner
AU3652102A (en) Compounds and their uses
IL151313A0 (en) Lipase containing pharmaceutical compositions
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
WO2004096234A3 (en) Kinase inhibitor phosphonate conjugates
MXPA05012026A (es) Compuestos de azaindol como inhibidores de cinasa.
PL345993A1 (en) Novel salt form of pantoprazole
IL172825A0 (en) Preparation of 1,3-diphenylprop-2-en-1-one derivatives
WO2002047604A3 (fr) Utilisation des composes de la classe des chalcones pour inhiber la vascularisation d'une masse tumorale
GB0103045D0 (en) Organic Compounds
WO2004060878A3 (en) Inhibitors of phosphatases
PL1628979T3 (pl) Związki diaminopirolochinazolinowe jako inhibitory białkowej fosfatazy tyrozynowej
WO2004020466A8 (en) Protein tyrosine phosphatase inhibitors
PL1633754T3 (pl) Związki diaminopirolochinazolinowe jako inhibitory białkowych fosfataz tyrozynowych
MXPA03005400A (es) Metodo para preparacion de 11 (12)-pentadecen-15-olidos.
MXPA04004757A (es) Uso de una ascomicina para el tratamiento de blefaritis.
DE69929802D1 (en) Lta4 hydrolase-hemmer
AU5155699A (en) Peptides for inhibiting hpv e7 proteins
MY119962A (en) Phosphoric acid salt of an aromatic diamin.

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)